We are live on ! Find out more
FOLD

Amicus Therapeutics
FOLD

Delisted

FOLD was delisted on the 24th of April, 2026.

Back to rankings

72 hedge funds and large institutions have $69.6M invested in Amicus Therapeutics in 2013 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

895% more call options, than puts

Call options by funds: $935K | Put options by funds: $94K

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

24% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 21

3% more funds holding

Funds holding: 70 → 72 (+2)

1% more capital invested

Capital invested by funds: $69.2M → $69.6M (+$420K)

Holders
72
Holders Change
+2
Holders Change %
+2.86%
% of All Funds
2.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
26
Reduced
21
Closed
8
Calls
$935K
Puts
$94K
Net Calls
+$841K
Net Calls Change
-$487K

Top Buyers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
+$3.04M
2
Morgan Stanley
Morgan Stanley
New York
+$692K
3
RIM
RS Investment Management
California
+$683K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$628K
5
BFA
BlackRock Fund Advisors
California
+$468K

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$3.31M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.23M
3
JP Morgan Chase
JP Morgan Chase
New York
-$634K
4
RA
Royce & Associates
New York
-$502K
5
TC
TFS Capital
Pennsylvania
-$417K
Name Holding Trade Value Shares
Change 		Change in
Stake
HVC
26
Healthcare Value Capital
New Jersey
$313K +$339K +135,000 New
Jacobs Levy Equity Management
27
Jacobs Levy Equity Management
New Jersey
$313K +$339K +135,046 New
DCM
28
Driehaus Capital Management
Illinois
$312K – – –
TCIM
29
TIAA CREF Investment Management
New York
$286K +$12.9K +5,126 +4%
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$272K – – –
AllianceBernstein
31
AllianceBernstein
Tennessee
$222K -$3.83K -1,526 -2%
Deutsche Bank
32
Deutsche Bank
Germany
$215K +$155K +61,746 +197%
Axa
33
Axa
France
$208K +$42.2K +16,822 +23%
BIM
34
BlackRock Investment Management
Delaware
$205K +$7.87K +3,138 +4%
Goldman Sachs
35
Goldman Sachs
New York
$168K -$5.13K -2,046 -3%
CS
36
Credit Suisse
Switzerland
$135K -$128K -50,881 -47%
Charles Schwab
37
Charles Schwab
California
$131K – – –
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$127K +$4.44K +1,768 +3%
PRHC
39
P.R. Herzig & Co
New York
$123K – – –
Dimensional Fund Advisors
40
Dimensional Fund Advisors
Texas
$116K +$103K +40,889 +440%
TA
41
Teachers Advisors
New York
$105K +$25.8K +10,285 +30%
ProShare Advisors
42
ProShare Advisors
Maryland
$85K +$19K +7,555 +26%
Nomura Holdings
43
Nomura Holdings
Japan
$82K -$5.18K -2,063 -6%
Brown Advisory
44
Brown Advisory
Maryland
$74K – – –
GH
45
GAM Holding
Switzerland
$74K +$79.5K +31,700 New
Public Employees Retirement Association of Colorado
46
Public Employees Retirement Association of Colorado
Colorado
$68K – – –
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$67K -$670 -267 -0.9%
DekaBank Deutsche Girozentrale
48
DekaBank Deutsche Girozentrale
Germany
$64K +$3.76K +1,500 +6%
VKH
49
Virtu KCG Holdings
New York
$61K +$65.5K +26,085 New
Citigroup
50
Citigroup
New York
$61K +$65.5K +26,101 +11,013%
1
2
3 4

FOLD Hedge Fund Activity: Q3 2013 in Review

72 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q3 2013, worth a combined $69.6M — up 0.61% from $69.2M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new FOLD positions and 8 closed out — a net gain of 2 holders — while 26 added to existing stakes and 21 trimmed.

The largest buyer was UBS AM, adding an estimated $3.04M. The largest seller was Wellington Management Group, exiting entirely with an estimated $3.31M sold.

  • 72 institutional investors held Amicus Therapeutics (FOLD) as of Q3 2013, up from 70 in Q2 2013.
  • Funds reported $69.6M of Amicus Therapeutics stock for Q3 2013, up 0.61% quarter-over-quarter.
  • 10 funds opened new Amicus Therapeutics positions in Q3 2013 and 8 closed out, a net change of +2 holders.
  • The largest Amicus Therapeutics buyer in Q3 2013 was UBS AM, an estimated $3.04M added.
  • The largest Amicus Therapeutics seller in Q3 2013 was Wellington Management Group, an estimated $3.31M sold.

Based on aggregated 13F filings for Q3 2013.